PAUL FINE to Leprosy
This is a "connection" page, showing publications PAUL FINE has written about Leprosy.
Connection Strength
0.570
-
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis. 2021 11; 21(11):1590-1597.
Score: 0.185
-
Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity. Lancet. 1994 Nov 05; 344(8932):1245-9.
Score: 0.116
-
Estimating the extent of household contact misclassification with index cases of disease in longitudinal studies using a stochastic simulation model. Glob Health Action. 2013 Jan 24; 6:19614.
Score: 0.103
-
Preliminary appraisal of a WHO-recommended multiple drug regimen in paucibacillary leprosy patients in Malawi. Int J Lepr Other Mycobact Dis. 1988 Sep; 56(3):408-17.
Score: 0.076
-
Leprosy in Malawi. 1. Sensitivity and specificity of the diagnosis and the search for risk factors for leprosy. Trans R Soc Trop Med Hyg. 1988; 82(6):803-9.
Score: 0.072
-
The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malawi. I. Methods. Lepr Rev. 1987 Dec; 58(4):359-75.
Score: 0.018